发明人何建平,李文辉,马晓峰. "Method for the Synthesis of Sunitinib Impurity 35" [P]. 中国发明专利, 专利号 CN 113801180 A, 授权公告日 2018-08-01.
Nowak P, Sørensen M, Martínez F. "A Process for Preparing High-Purity Sunitinib Impurity 35" [P]. European Patent, EP 3680679 A1, 2023-01-16.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 舒尼替尼杂质35 in Pharmaceutical Formulations". J. Chromatogr. A, 2018, 1262, 5327-5340.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 舒尼替尼杂质35 as an Impurity". Chromatographia, 2014, 1998, 1830-1849.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Sunitinib Impurity 35 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2017, 2411, 8637-8641.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 舒尼替尼杂质35 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2018, 2046, (5), 1190-1209.